Why this matters right now
Specifying Tyvek packaging hits the procurement desk fast. You gotta pick between off‑the‑shelf (COTS) and custom pouches and then prove your bioburden controls actually work. At trade shows like Medtec China I heard the same thing from designers and QA leads — speed, risk, and test proof matter. This guide breaks down where COTS saves time and where custom wins on performance, with concrete checks for bioburden, SAL targets, and retention testing. Also useful if you’ve got a booth at a medical device expo and need tidy answers for busy buyers. 😊
Snapshot: COTS vs Custom — real differences
COTS Tyvek pouches: fast lead times, defined materials, known suppliers. Good when your device geometry and sterilization method match standard options. Custom pouches: tailored cuts, special laminates, heat-seal offsets adjustable for unique trays. They cost more and take longer to validate, but they can reduce handling risk and improve packaging integrity.
Bioburden testing basics you must verify
Make sure the vendor’s protocol covers: sample size, extraction method, incubation limit, and acceptance criteria. Industry practice includes a 14‑day bioburden incubation limit for recovery checks — so confirm the lab uses that. Also confirm sterilization validation aims for a sterility assurance level (SAL) of 10^-6 when required by device class. Keep the language simple: extraction = how organisms are removed for counting; incubation = how long plates are held (14 days is common); report = CFU per device or per area.
What to ask suppliers — a short checklist
Ask for these documents and facts up front:
- Material spec for Tyvek and laminate, plus lot traceability.
- Bioburden protocol with sample size and 14‑day incubation limit noted.
- Seal strength and package integrity test results (watch for bubble leak or dye ingress data).
- Evidence of sterilization compatibility (e.g., validated for ethylene oxide, E‑beam, or steam).
- SAL target if sterilized before release (10^-6 where applicable).
Common mistakes I see — short, practical list
Companies skip one of these too often — don’t be that team. First, assuming supplier testing matches your device risk. Second, neglecting retention sample planning — keep samples for the full shelf life and include a plan for periodic bioburden checks. Third, treating Tyvek as uniform across types; different Tyvek grades change microbial ingress and seal behavior. — small detail, big consequence.
How to verify protocols in practice
Run a side‑by‑side validation: COTS pouch vs custom prototype. Use the same lots of Tyvek and the same sterilization process. Verify bioburden recovery with the agreed extraction method and incubate for the full 14 days. Track CFU counts and seal failures. If you need numbers for acceptance, align with your device’s risk class and your sterilization provider’s SOPs. Keep results in a controlled report for design history files and supplier qualifying documentation.
Alternatives and tradeoffs
If time is tight, qualify a COTS supplier fast by demanding batch test data and a copy of their bioburden protocol. If contamination risk is high or device shape is odd, invest in a custom pouch and plan for longer validation. Hybrid approach works too: start with COTS for pilot production, then switch to custom for scale if issues crop up.
Final quick rules — three golden metrics to use
Use these to pick and prove the right path: 1) Bioburden control — verify 14‑day incubation results and acceptable CFU thresholds for your risk class. 2) Packaging integrity — require passing seal strength and dye/bubble leak tests per lot. 3) Sterilization compatibility — confirm SAL goals (e.g., 10^-6) and that the pouch material is validated for your sterilization method.
Testing clarity wins time and reduces rework — that’s what manufacturers need at the show floor and on the production line. Medtec. — real help when specs meet reality.